Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

Blood Adv (2020) 4 (13): 3085–3092.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals